Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics

Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics

Pancreatic cancer is one of the most lethal tumors, and reliable detection of early-stage pancreatic cancer and risk diseases for pancreatic cancer is essential to improve the prognosis. As 260 genes were previously reported to be upregulated in invasive ductal adenocarcinoma of pancreas (IDACP) cel...

Full description

Bibliographic Details
Main Authors: Yoneyama, Toshihiro, Ohtsuki, Sumio, Honda, Kazufumi, Kobayashi, Makoto, Iwasaki, Motoki, Uchida, Yasuo, Okusaka, Takuji, Nakamori, Shoji, Shimahara, Masashi, Ueno, Takaaki, Tsuchida, Akihiko, Sata, Naohiro, Ioka, Tatsuya, Yasunami, Yohichi, Kosuge, Tomoo, Kaneda, Takashi, Kato, Takao, Yagihara, Kazuhiro, Fujita, Shigeyuki, Huang, Wilber, Yamada, Tesshi, Tachikawa, Masanori, Terasaki, Tetsuya
Format: Online
Language:English
Published: Public Library of Science 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007017/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007017/

Similar Items